GenMark Diagnostics (NASDAQ: GNMK), a Company developing molecular diagnostic tests based on its proprietary eSensor electrochemical detection technology, announced that the FDA has given the Company’s ePlex SARS-CoV-2 Test an emergency use authorization. The technology addresses a very important need for quick and easy detection...
TOMI Environmental Solutions (OTCQB: TOMZ), a Company that offers indoor and outdoor disinfection and decontamination services globally, announced a partnership with Rock Emergency, for the use of its SteraMist line of products, to combat the rapid spread of COVID-19 in the U.S. Rock Environment will...
Altimmune Inc (NASDAQ: ALT), a clinical stage biotechnology Company developing immunotherapies for unmet medical needs, announced that the Company has completed designing and synthesis of a novel single-dose, intranasal vaccine to protect against COVID-19, developed using its proprietary intranasal vaccine technology. [caption id="attachment_20787" align="aligncenter" width="271"] Image...
Inovio Pharmaceuticals (NASDAQ: INO), a late-stage biotechnology Company developing DNA-based immunotherapies and vaccines to combat cancer and infectious diseases, announced the grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for Coronavirus 2019-nCoV, a deadly new...
